SHIKARI® Q-NIVO
Matriks Biotek Nivolumab ELISA has been specially developed for the quantitative analysis of free Nivolumab in serum and plasma samples at high specificity.
SHIKARI® S-ATN
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
10ul
70 min
Serum, plasma
96
10ng/mL
85-115%
1 year
The Matriks Biotek anti-Nivolumab (Opdivo®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Nivolumab (Opdivo®) in serum and plasma.
It is for professional use only.
Calibration Curve
SHIKARI® Q-NIVO & S-ATN
Nivolumab (Opdivo®)
Enzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma
Enzyme immunoassay for the qualitative determination (screening) of antibodies to Nivolumab (Opdivo®) in serum and plasma
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
10ul
140 min
Serum, plasma
96
+/-
-
1 year
NIV-FD-OPD: $1000.00 Lead time: 1-2 weeks
NIV-QLS-OPD: $945.00 Lead time: 1-2 weeks
 | ||||
.....................................................
.....................................................
Drug Measurement
Anti-drug Antibody Measurement
Quantitative
Qualitative
Nivolumab (Opdivo®)
PD-1, PD-L1 and CTLA-4
Iwai North America Inc.
541 Taylor Way Suite# 4
San Carlos, CA 94070
Phone : (650) 486-1541
Fax : (650) 394-8638
Open weekdays 9 AM-6 PM (PST)
.........................................................................................................................................................................................................................................................
